2.50
price down icon1.13%   -0.010
 
loading
Biovie Inc stock is traded at $2.50, with a volume of 941.29K. It is down -1.13% in the last 24 hours and up +108.55% over the past month. BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$2.51
Open:
$2.57
24h Volume:
941.29K
Relative Volume:
0.20
Market Cap:
$44.06M
Revenue:
-
Net Income/Loss:
$-43.27M
P/E Ratio:
-1.6234
EPS:
-1.54
Net Cash Flow:
$-41.11M
1W Performance:
-3.06%
1M Performance:
+108.55%
6M Performance:
-49.39%
1Y Performance:
-93.95%
1-Day Range:
Value
$2.33
$2.57
1-Week Range:
Value
$2.33
$2.98
52-Week Range:
Value
$1.0404
$58.20

Biovie Inc Stock (BIVI) Company Profile

Name
Name
Biovie Inc
Name
Phone
775-888-3162
Name
Address
680 W NYE LANE, CARSON CITY
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
BIVI's Discussions on Twitter

Biovie Inc Stock (BIVI) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-22-22 Initiated Cantor Fitzgerald Overweight
Jan-15-21 Initiated B. Riley Securities Buy

Biovie Inc Stock (BIVI) Latest News

pulisher
Nov 04, 2024

BioVie's Upcoming Parkinson's Disease Clinical Trial is Fully Funded - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded - StockTitan

Nov 04, 2024
pulisher
Oct 30, 2024

BioVie Raises Capital Through Direct Stock Offering - MSN

Oct 30, 2024
pulisher
Oct 29, 2024

BioVie Inc. Announces Closing of Registered Direct Offering - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

BioVie Raises $3.24 Million in Direct Offering - TipRanks

Oct 29, 2024
pulisher
Oct 29, 2024

BioVie sets price for $3.2 million stock offering By Investing.com - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

BioVie prices stock offering at $2.83 per share By Investing.com - Investing.com Canada

Oct 29, 2024
pulisher
Oct 28, 2024

BIVIBioVie, Inc. Latest Stock News & Market Updates - StockTitan

Oct 28, 2024
pulisher
Oct 28, 2024

BioVie prices stock offering at $2.83 per share - Investing.com

Oct 28, 2024
pulisher
Oct 28, 2024

UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

BioVie sets price for $3.2 million stock offering - Investing.com India

Oct 28, 2024
pulisher
Oct 28, 2024

BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire

Oct 28, 2024
pulisher
Oct 26, 2024

Short Interest in BioVie Inc. (NASDAQ:BIVI) Decreases By 51.0% - MarketBeat

Oct 26, 2024
pulisher
Oct 26, 2024

BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Carson City, Nevada, October 23, 2024 — BioVie Inc. (NASDAQ: BIVI), a clinical-stage company focused on developing innovative drug therapies for ch - Defense World

Oct 26, 2024
pulisher
Oct 24, 2024

BioVie Raises $6 Million in Strategic Funding - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - StockTitan

Oct 24, 2024
pulisher
Oct 24, 2024

BioVie Announces $6 Million Stock Offering and Placement - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Oct 24, 2024
pulisher
Oct 23, 2024

BioVie announces $6 million stock offering and warrants By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie announces $6 million stock offering and warrants - Investing.com India

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie 2.667M share registered direct offering priced at $2.25 - TipRanks

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie Inc. Announces Pricing of Registered Direct Offering - GlobeNewswire

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie stock dips after pricing offering to raise $6.66M - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie Announces Stock Offering and Private Placement - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

Join BioVie's Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - The Manila Times

Oct 23, 2024
pulisher
Oct 23, 2024

Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - GlobeNewswire

Oct 23, 2024
pulisher
Oct 22, 2024

BioVie announces $6.7 million direct stock offering - Investing.com India

Oct 22, 2024
pulisher
Oct 22, 2024

BioVie Secures $6.66 Million Through Direct Offering - TipRanks

Oct 22, 2024
pulisher
Oct 22, 2024

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

3 Penny Stocks to Watch Now, 10/22/24 - TipRanks

Oct 22, 2024
pulisher
Oct 22, 2024

BioVie stock dips after pricing offering to raise $6.66M (NASDAQ:BIVI) - Seeking Alpha

Oct 22, 2024
pulisher
Oct 22, 2024

BioVie announces $6.7 million direct stock offering By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 21, 2024

BioVie 4.443M share registered direct offering priced at $1.50 - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Oct 21, 2024
pulisher
Oct 21, 2024

BioVie Sees Unusually Large Options Volume (NASDAQ:BIVI) - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Oct 21, 2024
pulisher
Oct 21, 2024

BioVie (BIVI) Stock Surges After Hours On A Patent Milestone - Stocks Telegraph

Oct 21, 2024
pulisher
Oct 21, 2024

BIVI Stock Quote Price and Forecast - CNN

Oct 21, 2024
pulisher
Oct 15, 2024

BioVie secures patent for terlipressin formulation - Investing.com India

Oct 15, 2024
pulisher
Oct 15, 2024

BioVie secures patent for terlipressin formulation By Investing.com - Investing.com UK

Oct 15, 2024
pulisher
Oct 15, 2024

BioVie Receives Notice of Allowance for Japan Patent Application Covering Novel Liquid Formulation of Terlipressin - GlobeNewswire

Oct 15, 2024

Biovie Inc Stock (BIVI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Biovie Inc Stock (BIVI) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
DO CUONG V
President & CEO
Nov 30 '23
Buy
1.78
10,000
17,800
68,759
$20.30
price up icon 1.75%
$75.59
price down icon 0.20%
$374.10
price down icon 0.29%
$52.67
price down icon 0.85%
$207.67
price up icon 0.20%
$108.59
price up icon 0.02%
Cap:     |  Volume (24h):